Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, Davis Dr. Vicki Wheelock Disease Team Therapy Development – Research MSC engineered to produce BDNF for the treatment of Huntington’s disease $8,924,235
StemCells, Inc. Dr. Nobuko Uchida Disease Team Therapy Development – Research Neural stem cell transplantation for chronic cervical spinal cord injury $0
University of California, Davis Nancy E. Lane Disease Team Therapy Development – Research Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells $18,227,898
Salk Institute for Biological Studies Dr. David R Schubert Early Translational III Stem cell based small molecule therapy for Alzheimer’s disease $1,673,757
City of Hope, Beckman Research Institute Dr. Stephen J Forman Early Translational III Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells $5,215,447
Gladstone Institutes, J. David Dr. Deepak Srivastava Early Translational III Direct Cardiac Reprogramming for Heart Regeneration $5,795,871
University of California, San Diego Dr. Lawrence S. B. Goldstein Early Translational III Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells $1,774,420
University of California, San Diego Dr. Yang Xu Early Translational III Human ES cell based therapy of heart failure without allogenic immune rejection $1,857,600
Stanford University Dr. Joseph C. Wu Early Translational III Heart Repair with Human Tissue Engineered Myocardium $4,395,080
University of California, San Francisco Mort Cowan Early Translational III Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID $3,862,367
Stanford University Professor Helen M. Blau PhD Early Translational III Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,283
University of Southern California Dr. Toshio Miki Early Translational III Generation of hepatic cell from placental stem cell for congenital metabolic disorders $1,750,375
Children’s Hospital of Orange County Dr. Philip H Schwartz Early Translational III Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease $4,266,015
University of California, San Francisco Dr. Holger F Willenbring Early Translational III Generation of safe and therapeutically effective human induced hepatocyte-like cells $1,544,170
Salk Institute for Biological Studies Juan Carlos Izpisua Belmonte Early Translational III Direct reprogramming towards vascular progenitors for the treatment of ischemia $2,340,000
University of California, San Diego Dr. Eric D. Adler MD Early Translational III Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease $1,701,575
University of California, Davis Walter Douglas Boyd Early Translational III Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair $4,631,754
Stanford University Dr. Bertha Chen Early Translational III Autologous iPSC Therapy for Urinary Incontinence $4,715,738
University of California, San Diego Mark H Tuszynski Early Translational III Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury $4,600,447
University of California, Davis Prof. Kyriacos A. Athanasiou Ph.D Early Translational III Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells $1,735,703
University of California, Irvine Craig M. Walsh Early Translational III Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells $4,535,005
Scripps Research Institute Peter G. Schultz Early Translational III Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis $2,559,333
University of California, San Francisco Dr. Arnold Kriegstein Early Translational III Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury $1,623,251
University of California, San Diego Gene Wei-Ming Yeo Early Translational III Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons $1,532,323
University of California, Santa Cruz Dr. David Haussler Training Grant I-3 Training Program in Systems Biology of Stem Cells $1,133,701
University of California, Santa Barbara Dr. Dennis O. Clegg Training Grant I-3 UCSB Stem Cell Biology Training Program $975,334
Salk Institute for Biological Studies Juan Carlos Izpisua Belmonte Training Grant I-3 Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies $1,261,333
California Institute of Technology Paul H. Patterson Training Grant I-2 Training in Stem Cell Biology at CIT $1,817,214
Children’s Hospital of Los Angeles Dr. Donald B. Kohn Training Grant I-2 Training Grant 1 $2,173,872
Sanford Burnham Prebys Medical Discovery Institute Dr. Mark Mercola Training Grant I-2 Burnham Institute CIRM Stem Cell Training Grant (Type II) $1,061,865
Gladstone Institutes, J. David Dr. Robert W Mahley Training Grant I-2 Gladstone CIRM Scholar Program $2,192,073
Scripps Research Institute Peter G. Schultz Training Grant I-2 Training Grant I $1,021,395
University of California, Davis Dr. Frederick J Meyers MD Training Grant I-1 Stem Cell Research Training Grant $1,780,859
University of California, San Francisco Dr. Susan J Fisher PhD Training Grant I-1 Training Grant I $2,868,145
University of California, Los Angeles Dr. Owen N Witte M.D. Training Grant I-1 CIRM Type I Comprehensive Training Program $3,660,398
University of Southern California Dr. Robert E Maxson Training Grant I-1 CIRM Stem Cell Biology Training Grant $2,332,431
University of California, Irvine Dr. Peter Bryant Training Grant I-1 Stem Cell Research Training Grant $1,935,487
University of California, Berkeley Randy W. Schekman Training Grant I-1 Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland $2,360,457
University of California, San Diego Dr. Lawrence S. B. Goldstein Training Grant I-1 Interdisciplinary Stem Cell Training Program at UCSD $3,459,396
Stanford University Michael T. Longaker M.D. Training Grant I-1 Stanford CIRM Training Program $3,035,282
University of California, Davis Dr Mehrdad Abedi Disease Team Therapy Planning I Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients $66,880
University of California, Davis Dr. John Laird Disease Team Therapy Planning I Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia $76,066
University of California, Davis Dr. Vicki Wheelock Disease Team Therapy Planning I MSC engineered to produce BDNF for the treatment of Huntington’s disease $97,564
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
Stanford University Dr. Albert J Wong Disease Team Therapy Planning I Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Stanford University Dr. Judith A Shizuru Disease Team Therapy Planning I A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
OncoMed Pharmaceuticals, Inc. Timothy Hoey Disease Team Therapy Planning I Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency $65,120
Cedars-Sinai Medical Center Dr. Dan Gazit Disease Team Therapy Planning I Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. $107,622
StemCells, Inc. Dr. Alexandra Capela Disease Team Therapy Planning I Neuroprotection to treat Alzheimer’s: a new paradigm using human central nervous system cells $90,101
University of California, Los Angeles Dr. Stanley Nelson Disease Team Therapy Planning I Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $68,947
1 … 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 … 31

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More